NCT00495924
- Conditions
- Adenocarcinoma, Carcinoma, Digestive System Diseases, +17 more
- Locations
-
- Department of Abdominal Surgery, Catholic University Leuven Leuven, Vlaams-Brabant, Belgium
Clinical trial condition
Adenocarcinoma
Explore clinical trials studying Adenocarcinoma. Study availability and eligibility vary by location and protocol.
124 public trials
18 recruiting studies
Adenocarcinoma trial results
NCT00259987
- Conditions
- Adenocarcinoma, Carcinoma, Neoplasms, +2 more
- Locations
-
- GSK Investigational Site Los Angeles, California, United States
- GSK Investigational Site Ann Arbor, Michigan, United States
- GSK Investigational Site Buffalo, New York, United States
- GSK Investigational Site Amsterdam, Netherlands
NCT00102700
- Conditions
- Adenocarcinoma, Carcinoma, Digestive System Diseases, +10 more
- Locations
-
- University of South Alabama Mobile, Alabama, United States
- Moores UCSD Cancer Center La Jolla, California, United States
- Desert Hematology Oncology Medical Group, Inc. Rancho Mirage, California, United States
- Scripps Cancer Center San Diego, California, United States
NCT00377936
- Conditions
- Adenocarcinoma, Carcinoma, Digestive System Diseases, +15 more
- Locations
-
- Prague, Czechia
- Budapest, Hungary
- Kiev, Ukraine
Completed
Study of Motexafin Gadolinium (MGd) for Second Line Treatment of Non-Small-Cell Lung Cancer
NCT00129844
- Conditions
- Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +12 more
- Locations
-
- Fountain Valley, California, United States
- Los Angeles, California, United States
- Palm Springs, California, United States
- Columbia, Missouri, United States
Completed
A Long Term Safety Study With Atrasentan
NCT00127478
- Conditions
- Adenocarcinoma, Carcinoma, Genital Diseases, +12 more
- Locations
-
- Prostate Oncology Specialists Marina del Rey, California, United States
- Western Clinical Research, Inc. Torrance, California, United States
- South Florida Medical Research Aventura, Florida, United States
- Beth Isreal Medical Center, Phillips Ambulatory Care Ceneter New York, United States
NCT00191503
- Conditions
- Adenocarcinoma, Carcinoma, Neoplasms, +2 more
- Locations
-
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Calgary, Alberta, Canada
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Edmonton, Alberta, Canada
Completed
Tezacitabine With or Without 5-Fluorouracil (5-FU) for Advanced Esophageal Cancer or Gastric Cancer
NCT00054873
- Conditions
- Adenocarcinoma, Adenocarcinoma Of Esophagus, Carcinoma, +13 more
- Locations
-
- University of Alabama at Birmingham Birmingham, Alabama, United States
- ACRC/Arizona Clinical Research Center Tucson, Arizona, United States
- Glendale Memorial Hospital Glendale, California, United States
- USC/Norris Comprehensive Cancer Center Los Angeles, California, United States
NCT00051675
- Conditions
- Adenocarcinoma, Carcinoma, Neoplasms, +2 more
- Locations
-
- Jack D. Weiler Hospital of the Albert Einstein College of Medicine The Bronx, New York, United States
Active, Not Recruiting
Novel SEQUEnced Immunotherapy With Anti-angiogenesis and Chemotherapy in Advanced gastroesophageaL Adenocarcinoma
NCT04069273
- Conditions
- Adenocarcinoma, Carcinoma, Digestive System Diseases, +11 more
- Locations
-
- Mayo Clinic- Minnesota Rochester, Minnesota, United States
- Froedtert and The Medical College of Wisconsin Milwaukee, Wisconsin, United States